Eli Lilly
Trade Eli Lilly 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About LLY
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies.
LLY Key Statistics
Stock Snapshot
Eli Lilly(LLY) stock is priced at $1,217.92, giving the company a market capitalization of 1.22T. It carries a P/E multiple of 40.36 and pays a dividend yield of 0.58%.
On 2026-08-10, Eli Lilly(LLY) stock traded between a low of $1,180.00 and a high of $1,218.88. Shares are currently priced at $1,217.92, which is +3.2% above the low and -0.1% below the high.
The Eli Lilly(LLY)'s current trading volume is 1.26M, compared to an average daily volume of 3.19M.
During the past year, Eli Lilly(LLY) stock moved between $623.78 at its lowest and $1,249.45 at its peak.
During the past year, Eli Lilly(LLY) stock moved between $623.78 at its lowest and $1,249.45 at its peak.
LLY News
These 7 Stocks Are Analyst Favorites For Magnificent Earnings Growth; Arista Beats Views 8/08/2026 Among the best stocks in earnings performance, highly rated...
...
Markets Nvidia, Eli Lilly, and Disney Show It’s Time to Back the Top Dogs In this article NVDA LLY DIS AMD NVO Eli Lilly, Disney and Nvidia have asserted their...
Analyst ratings
81%
of 31 ratingsMore LLY News
Eli Lilly stock has climbed very sharply over the past five years, yet the current valuation checks send a more measured signal, with the Discounted Cash Flow (...
In this episode of Motley Fool Hidden Gems Investing, Motley Fool contributors Travis Hoium and Lou Whiteman, along with Motley Fool analyst Jason Moser, discus...
Key Points Eli Lilly leads the GLP-1 market and could remain on top thanks to a deep pipeline. Viking Therapeutics' leading GLP-1 candidate looks very promisi...
Key Points Eli Lilly should request approval for retatrutide early next year. This medicine could help the company expand the weight loss market. The drugmak...
Truist raised the firm’s price target on Eli Lilly (LLY) to $1,376 from $1,370 and keeps a Buy rating on the shares. Eli Lilly delivered strong Q2 performance w...
Key Points Investors often use sector ETFs to tilt their portfolios towards a specific theme. In reality, most market-cap-weighted sector ETFs are simply bets...
Read Between These Lines As Eli Lilly, Hot IPO And More Face Key Test 8/03/2026 As stocks like Eli Lilly, Twilio, Hinge Health and more move ahead of earnings...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.